Overview AI is speeding up drug discovery by analyzing large biological and chemical data in a short time.Deep learning and AI systems help design new drug mole ...

Deep EigenMatics, Inc., a pioneer in high-velocity Artificial Intelligence for drug design, announced today that it has secured the #1 global ranking for new U.S. patent families in AI Drug Discovery ...

In the pursuit of solutions to complex global challenges including disease, energy demands, and climate change, scientific ...

A new generation of artificial intelligence is starting to read the human genome with a fluency that would have sounded like ...

The global artificial intelligence (AI) in drug discovery market is experiencing rapid expansion, driven by the need to reduce the high costs and long timelines of traditional pharmaceutical ...

AI has fundamentally altered the feasibility of natural product discovery from fungal endophytes. Advances in genome sequencing, metabolomics, and systems biology have generated vast datasets, but ...

The rapid advancement of artificial intelligence (AI) is transforming the field of structural biology. In May 2024, DeepMind and Isomorphic Labs launched AlphaFold 3 (AF3), a revolutionary AI system ...

SAN FRANCISCO (KRON) – As the use of artificial intelligence becomes a more popular tool in drug research, a scientific software company aims to one day use the technology to predict future medicines.

This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...

In 2023, North America dominated the the global AI in drug discovery market and is poised to maintain this leadership during the forecast period. The US FDA’s proactive stance on approving drug ...